Phosphorylated 4E-BP1 is associated with poor survival in melanoma
KE O'Reilly, M Warycha, MA Davies, V Rodrik… - Clinical Cancer …, 2009 - AACR
KE O'Reilly, M Warycha, MA Davies, V Rodrik, XK Zhou, H Yee, D Polsky, AC Pavlick…
Clinical Cancer Research, 2009•AACRAbstract Purpose: Both phosphatidylinositol 3-kinase/AKT and RAS/mitogen-activated
protein kinase signal transduction pathways mediate 4E-BP1 phosphorylation, releasing 4E-
BP1 from the mRNA cap and permitting translation initiation. Given the prevalence of PTEN
and BRAF mutations in melanoma, we first examined translation initiation, as measured by
phosphorylated 4E-BP1 (p-4E-BP1), in metastatic melanoma tissues and cell lines. We then
tested the association between amounts of total and p-4E-BP1 and patient survival …
protein kinase signal transduction pathways mediate 4E-BP1 phosphorylation, releasing 4E-
BP1 from the mRNA cap and permitting translation initiation. Given the prevalence of PTEN
and BRAF mutations in melanoma, we first examined translation initiation, as measured by
phosphorylated 4E-BP1 (p-4E-BP1), in metastatic melanoma tissues and cell lines. We then
tested the association between amounts of total and p-4E-BP1 and patient survival …
Abstract
Purpose: Both phosphatidylinositol 3-kinase/AKT and RAS/mitogen-activated protein kinase signal transduction pathways mediate 4E-BP1 phosphorylation, releasing 4E-BP1 from the mRNA cap and permitting translation initiation. Given the prevalence of PTEN and BRAF mutations in melanoma, we first examined translation initiation, as measured by phosphorylated 4E-BP1 (p-4E-BP1), in metastatic melanoma tissues and cell lines. We then tested the association between amounts of total and p-4E-BP1 and patient survival.
Experimental Design: Seven human metastatic melanoma cells lines and 72 metastatic melanoma patients with accessible metastatic tumor tissues and extended follow-up information were studied. Expression of 4E-BP1 transcript, total 4E-BP1 protein, and p-4E-BP1 was examined. The relationship between 4E-BP1 transcript and protein expression was assessed in a subset of patient tumors (n = 41). The association between total and p-4E-BP1 levels and survival was examined in the larger cohort of patients (n = 72).
Results: 4E-BP1 was hyperphosphorylated in 4 of 7 melanoma cell lines harboring both BRAF and PTEN mutations compared with untransformed melanocytes or RAS/RAF/PTEN wild-type melanoma cells. 4E-BP1 transcript correlated with 4E-BP1 total protein levels as measured by the semiquantitative reverse-phase protein array (P = 0.012). High levels of p-4E-BP1 were associated with worse overall and post-recurrence survival (P = 0.02 and 0.0003, respectively).
Conclusion: Our data show that translation initiation is a common event in human metastatic melanoma and correlates with worse prognosis. Therefore, effective inhibition of the pathways responsible for 4E-BP1 phosphorylation should be considered to improve the treatment outcome of metastatic melanoma patients.
AACR